Correction to: Oncogene
10.1038/s41388-019-0927-y
The original version of this article contained an error in the spelling of the author David Solow-Cordero, which was incorrectly given as David Solow-Codero.
. 2019 Oct 28;39(9):2029. doi: 10.1038/s41388-019-1077-y
Correction: Casein kinase 2 inhibition sensitizes medulloblastoma to temozolomide
Ryan T Nitta
1,✉, Sara Bolin
1, Emily Luo
1, David E Solow-Cordero
2, Peyman Samghabadi
3, Teresa Purzner
4,5, Parvir S Aujla
1, Ginikachi Nwagbo
1, Yoon-Jae Cho
6, Gordon Li
1
Ryan T Nitta
1Department of Neurosurgery, Stanford University, Stanford, CA USA
Find articles by Ryan T Nitta
Sara Bolin
1Department of Neurosurgery, Stanford University, Stanford, CA USA
Find articles by Sara Bolin
Emily Luo
1Department of Neurosurgery, Stanford University, Stanford, CA USA
Find articles by Emily Luo
David E Solow-Cordero
2High-Throughput Bioscience Center, Department of Chemical and Systems Biology, Stanford University, Stanford, CA USA
Find articles by David E Solow-Cordero
Peyman Samghabadi
3Department of Neuropathology, Stanford University, Stanford, CA USA
Find articles by Peyman Samghabadi
Teresa Purzner
4Department of Developmental Biology, Stanford University, Stanford, CA USA
5Division of Neurosurgery, University of Toronto, Toronto, ON Canada
Find articles by Teresa Purzner
Parvir S Aujla
1Department of Neurosurgery, Stanford University, Stanford, CA USA
Find articles by Parvir S Aujla
Ginikachi Nwagbo
1Department of Neurosurgery, Stanford University, Stanford, CA USA
Find articles by Ginikachi Nwagbo
Yoon-Jae Cho
6Department of Pediatrics, Papé Family Pediatric Research Institute, Knight Cancer Institute, Oregon Health & Science University, Portland, OR USA
Find articles by Yoon-Jae Cho
Gordon Li
1Department of Neurosurgery, Stanford University, Stanford, CA USA
Find articles by Gordon Li
1Department of Neurosurgery, Stanford University, Stanford, CA USA
2High-Throughput Bioscience Center, Department of Chemical and Systems Biology, Stanford University, Stanford, CA USA
3Department of Neuropathology, Stanford University, Stanford, CA USA
4Department of Developmental Biology, Stanford University, Stanford, CA USA
5Division of Neurosurgery, University of Toronto, Toronto, ON Canada
6Department of Pediatrics, Papé Family Pediatric Research Institute, Knight Cancer Institute, Oregon Health & Science University, Portland, OR USA
✉
Corresponding author.
Issue date 2020.
Subject terms: CNS cancer, Diagnostic markers
© The Author(s) 2019
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
PMCID: PMC8075939 PMID: 31659253
This corrects the article "Casein Kinase 2 inhibition sensitizes medulloblastoma to temozolomide" in volume 38 on page 6867.